Skip to main content
BMJ Open Access logoLink to BMJ Open Access
. 2019 Dec 16;79(1):e12. doi: 10.1136/annrheumdis-2019-215356corr1

Correction: The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies. A meta-analysis and functional study

PMCID: PMC6937404  PMID: 31843990

McGonagle DG, McInnes IB, Kirkham BW, et al. The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies. A meta-analysis and functional study. Ann of Rheum Dis 2019;78:1167–78. doi: 10.1136/annrheumdis-2019-215356.

Figure 4 is amended to reflect the lack of definitive, controlled clinical evidence of prevention of structural progression by secukinumab in axial spondyloarthritis.

graphic file with name annrheumdis-2019-215356corr1ilf02.jpg


Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES